ESC Professional Premium Access

Effect of rivaroxaban monotherapy vs. combination with anti-platelet therapy in patients with atrial fibrillation and stable coronary artery disease across different body mass index categories

Congress Presentation

About the speaker

Doctor Masanobu Ishii

Kumamoto University Hospital, Kumamoto (Japan)
0 follower

4 more presentations in this session

Sodium-glucose co-transporter-2 inhibitors after acute myocardial infarction in type 2 diabetes patients: a population-based investigation from South Korea

Speaker: Doctor O. Kwon (Seoul, KR)


Activation of mitochondrial telomerase reverses relative lymphopenia post myocardial infarction: results from the randomised, double-blinded TACTIC phase IIa pilot trial

Speaker: Professor I. Spyridopoulos (Newcastle-Upon-Tyne, GB)


Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Speaker: Doctor M. Pareek (Copenhagen, DK)


Direct cost analysis of genetic testing for CYP2C19*2 and *3 loss of function variants in percutaneous coronary intervention patients

Speaker: Doctor S. Huxley (Rochester, US)


Access the full session

Coronary artery disease - Pharmacotherapy 1

Speakers: Doctor M. Ishii, Doctor O. Kwon, Professor I. Spyridopoulos, Doctor M. Pareek, Doctor S. Huxley

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb